rs363075
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001388492.1(HTT):c.2677G>A(p.Gly893Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0526 in 1,603,158 control chromosomes in the GnomAD database, including 2,493 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.041 ( 168 hom., cov: 32)
Exomes 𝑓: 0.054 ( 2325 hom. )
Consequence
HTT
NM_001388492.1 missense
NM_001388492.1 missense
Scores
2
10
6
Clinical Significance
Conservation
PhyloP100: 5.74
Publications
23 publications found
Genes affected
HTT (HGNC:4851): (huntingtin) Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range of trinucleotide repeats (9-35) has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2016]
HTT Gene-Disease associations (from GenCC):
- Huntington diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- Lopes-Maciel-Rodan syndromeInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- juvenile Huntington diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.002583623).
BP6
Variant 4-3135947-G-A is Benign according to our data. Variant chr4-3135947-G-A is described in ClinVar as Benign. ClinVar VariationId is 1615277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0589 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0408 AC: 6210AN: 152172Hom.: 168 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
6210
AN:
152172
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0414 AC: 9882AN: 238800 AF XY: 0.0421 show subpopulations
GnomAD2 exomes
AF:
AC:
9882
AN:
238800
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0538 AC: 78062AN: 1450868Hom.: 2325 Cov.: 29 AF XY: 0.0528 AC XY: 38139AN XY: 721730 show subpopulations
GnomAD4 exome
AF:
AC:
78062
AN:
1450868
Hom.:
Cov.:
29
AF XY:
AC XY:
38139
AN XY:
721730
show subpopulations
African (AFR)
AF:
AC:
290
AN:
32866
American (AMR)
AF:
AC:
1578
AN:
42008
Ashkenazi Jewish (ASJ)
AF:
AC:
801
AN:
25920
East Asian (EAS)
AF:
AC:
4
AN:
39294
South Asian (SAS)
AF:
AC:
1618
AN:
83902
European-Finnish (FIN)
AF:
AC:
2151
AN:
53304
Middle Eastern (MID)
AF:
AC:
287
AN:
5722
European-Non Finnish (NFE)
AF:
AC:
68356
AN:
1107892
Other (OTH)
AF:
AC:
2977
AN:
59960
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
3115
6230
9345
12460
15575
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2484
4968
7452
9936
12420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0408 AC: 6211AN: 152290Hom.: 168 Cov.: 32 AF XY: 0.0393 AC XY: 2925AN XY: 74466 show subpopulations
GnomAD4 genome
AF:
AC:
6211
AN:
152290
Hom.:
Cov.:
32
AF XY:
AC XY:
2925
AN XY:
74466
show subpopulations
African (AFR)
AF:
AC:
461
AN:
41570
American (AMR)
AF:
AC:
792
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
112
AN:
3472
East Asian (EAS)
AF:
AC:
1
AN:
5192
South Asian (SAS)
AF:
AC:
100
AN:
4824
European-Finnish (FIN)
AF:
AC:
465
AN:
10606
Middle Eastern (MID)
AF:
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4111
AN:
68010
Other (OTH)
AF:
AC:
111
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
305
610
914
1219
1524
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
228
ALSPAC
AF:
AC:
236
ESP6500AA
AF:
AC:
49
ESP6500EA
AF:
AC:
492
ExAC
AF:
AC:
5135
Asia WGS
AF:
AC:
38
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Pathogenic
DEOGEN2
Uncertain
D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
M
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MutPred
Gain of solvent accessibility (P = 0.0171);
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.